PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1447633
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1447633
Global Intravenous Catheters Market size will witness 7.8% CAGR between 2024 and 2032 due to the proliferation of devices compatible with catheters and promising enhanced healthcare outcomes. With continuous advancements, these devices offer improved compatibility and functionality for addressing various patient needs. For instance, in November 2023, BD (Becton, Dickinson and Company), a prominent global medical technology firm, introduced innovative needle-free blood draw technology with design enhancements to work seamlessly with integrated catheters. The newly launched PIVO Pro Needle-free Blood Collection Device received 510(k) clearance from the U.S. FDA.
The growing focus of the healthcare industry on providing safer and more effective intravenous therapies will also add to the product demand. By providing better access, reduced risk of complications, and enhanced patient comfort, these innovations are helping elevate the standard of care. The imperative for superior healthcare delivery is another factor driving the market expansion.
The overall intravenous catheters industry is classified into product type, gauge size, lumen, material, end-use, and region.
Based on product, the market value from the midline peripheral catheter segment will undergo significant development, depicting 7% CAGR from 2024 to 2032. These catheters, positioned between traditional peripheral and central lines, offer a balance of accessibility and longevity, making them increasingly favored for various medical procedures. With benefits including reduced complications and improved patient comfort, healthcare providers are increasingly turning to midline catheters. With the emerging trend towards minimally invasive procedures, the demand for midline peripheral catheters is expected to fuel.
Intravenous catheters market revenue from the ambulatory surgical centers end-use segment will register 8.8% CAGR from 2024 to 2032. As ambulatory surgical centers (ASCs) perform an increasing number of outpatient procedures, the need for efficient and reliable intravenous access has turned paramount. Intravenous catheters enable safe and convenient delivery of medications and fluids during surgical and diagnostic procedures for optimizing patient care and recovery. With ASCs prioritizing cost-effective and minimally invasive solutions, the demand for innovative intravenous catheters tailored to their unique requirements is escalating, propelling the segment growth.
Europe intravenous catheters market size will showcase 7.3% CAGR from 2024 to 2032. Rising healthcare expenditure and an aging population will drive the need for advanced medical devices, including intravenous catheters across the region to support a wide range of clinical applications. As European healthcare facilities prioritize efficiency, infection control, and patient comfort, there is a growing demand for innovative intravenous catheters tailored to meet stringent requirements. This trend may favor the regional market growth. For instance, in 2023, the Introcan Safety 2 IV Catheter was introduced by B. Braun Medical featuring multi-access blood control to reduce the risk of exposure to bloodborne pathogens during IV procedures.